Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations

Article Properties
  • Language
    English
  • Publication Date
    2006/10/01
  • Indian UGC (journal)
  • Refrences
    11
  • Citations
    42
  • Peter F. Thall a Department of Biostatistics and Applied Mathematics , The University of Texas , Houston , Texas , USA
  • John D. Cook a Department of Biostatistics and Applied Mathematics , The University of Texas , Houston , Texas , USA
  • Elihu H. Estey b Department of Leukemia , The University of Texas , Houston , Texas , USA
Cite
Thall, Peter F., et al. “Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations”. Journal of Biopharmaceutical Statistics, vol. 16, no. 5, 2006, pp. 623-38, https://doi.org/10.1080/10543400600860394.
Thall, P. F., Cook, J. D., & Estey, E. H. (2006). Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations. Journal of Biopharmaceutical Statistics, 16(5), 623-638. https://doi.org/10.1080/10543400600860394
Thall, Peter F., John D. Cook, and Elihu H. Estey. “Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations”. Journal of Biopharmaceutical Statistics 16, no. 5 (2006): 623-38. https://doi.org/10.1080/10543400600860394.
Thall PF, Cook JD, Estey EH. Adaptive Dose Selection Using Efficacy-Toxicity Trade-Offs: Illustrations and Practical Considerations. Journal of Biopharmaceutical Statistics. 2006;16(5):623-38.
Refrences
Title Journal Journal Categories Citations Publication Date
Play the Winner Rule and the Controlled Clinical Trial Journal of the American Statistical Association
  • Science: Mathematics: Probabilities. Mathematical statistics
  • Science: Mathematics
200 1969
Selecting Therapeutic Strategies Based on Efficacy and Death in Multicourse Clinical Trials Journal of the American Statistical Association
  • Science: Mathematics: Probabilities. Mathematical statistics
  • Science: Mathematics
60 2002
10.1111/j.0006-341X.2004.00218.x
Correlated Binary Regression with Covariates Specific to Each Binary Observation Biometrics
  • Science: Biology (General)
  • Medicine: Medicine (General): Computer applications to medicine. Medical informatics
  • Science: Biology (General)
  • Science: Mathematics: Probabilities. Mathematical statistics
  • Science: Mathematics
466 1988
10.1111/j.0006-341X.2001.01018.x
Citations
Title Journal Journal Categories Citations Publication Date
Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial The Lancet Oncology
  • Medicine: Medicine (General)
  • Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
2023
DROID: Dose-Ranging Approach to Optimizing Dose in Oncology Drug Development

Biometrics
  • Science: Biology (General)
  • Medicine: Medicine (General): Computer applications to medicine. Medical informatics
  • Science: Biology (General)
  • Science: Mathematics: Probabilities. Mathematical statistics
  • Science: Mathematics
7 2023
Nature-inspired Metaheuristics for finding Optimal Designs for the Continuation-Ratio Models

The New England Journal of Statistics in Data Science 2023
Estimating design operating characteristics in Bayesian adaptive clinical trials

Canadian Journal of Statistics
  • Science: Mathematics: Probabilities. Mathematical statistics
  • Science: Mathematics
5 2022
Efficacy-Driven Dose Finding with Toxicity Control in Phase I Oncology Studies Statistics in Biosciences
  • Medicine: Medicine (General): Computer applications to medicine. Medical informatics
  • Science: Biology (General)
2021
Citations Analysis
The category Science: Mathematics: Probabilities. Mathematical statistics 15 is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Recent Developments in Adaptive Designs for Phase I/II Dose-Finding Studies and was published in 2007. The most recent citation comes from a 2023 study titled Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial. This article reached its peak citation in 2019, with 7 citations. It has been cited in 30 different journals, 13% of which are open access. Among related journals, the Contemporary Clinical Trials Communications cited this research the most, with 4 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year